SPY424.26-1.00 -0.24%
DIA343.32-0.98 -0.28%
IXIC14,067.21-106.94 -0.75%

Morgan Stanley Maintains Overweight on BeiGene, Lowers Price Target to $357

Morgan Stanley maintains BeiGene (NASDAQ:BGNE) with a Overweight and lowers the price target from $375 to $357.

05/10/2021 07:48
Morgan Stanley maintains BeiGene (NASDAQ:BGNE) with a Overweight and lowers the price target from $375 to $357.